FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2762677209> ?p ?o ?g. }

• W2762677209 endingPage "158" @default.
• W2762677209 startingPage "158" @default.
• W2762677209 abstract "Abstract Introduction Innate immune complement activation may contribute to sickle cell disease (SCD) pathogenesis. The alternative complement pathway is abnormally activated in SCD and is additionally activated by phosphatidylserine (PS) on the outer leaflet of SS-red blood cells (SS-RBC). PS on the surface of SS-RBC and activated platelets accelerates the assembly of prothrombinase complexes leading to generation of thrombin, which can cleave circulating C5 protein into two biologically active fragments, C5a and C5b. C5a is an anaphylatoxin, a potent pro-inflammatory mediator, that can activate leukocytes, platelets, and endothelial cells, all of which play a role in vaso-occlusion (VO). Active C5b fragments stimulate the formation of membrane attack complexes (MAC) on SS-RBC that increases their susceptibility to lysis. We hypothesize that complement activation on the surface of SS-RBC may stimulate VO and RBC turnover in SCD. Methods and Results Whole blood from Townes-AA, -AS, and -SS mice (n=4) was collected in EDTA and RBC were immunostained with erythroid specific anti-Ter119 (Ly-76) IgG conjugated to PE-Cy7, anti-C5b-9 (MAC) IgG conjugated to Alexa Fluor 647, and anti-C3 (also specific for activation fragments C3b, iC3b, C3d and C3dg) IgG conjugated to PE. The percentages of Ter119-positive RBC that were positive for MAC were 6.3%, 6.5%, and 26.0% for AA-, AS-, and SS-RBCs, respectively (p<0.01 SS vs. AA and AS) suggesting enhanced C5 activation in Townes-SS mice. However, EDTA plasma C5a levels measured by ELISA were not significantly different between Townes-AA, -AS and -SS mice. C3 activation fragments were also found on a subset of MAC positive RBC. We used a mouse model of hypoxia/reoxygenation (H/R)-induced stasis to investigate the role of complement in VO. Townes-SS mice with implanted dorsal skin-fold chambers were infused with 30 µg of either anti-C5 IgG mAb BB5.1 (which blocks murine C5 cleavage ) (n=4), annexin V (n=2), or with isotype control IgG (n=4) 30 minutes prior to H/R (1 hour of hypoxia at 7% O2, followed by reoxygenation for 4 hours in room air). Percent microvascular stasis (% non-flowing venules) in the subcutaneous venules in the dorsal skin fold chamber window was measured using intravital microscopy at 1 and 4 hours post-hypoxia. Percent stasis was significantly lower in the Townes-SS mice receiving anti-C5 IgG or annexin V than the mice receiving the isotype control IgG at 1 and 4 hours post-hypoxia (Figure 1, means ± SD, *p<0.01 anti-C5 IgG or annexin V vs. control IgG). This finding implies that H/R may acutely activate C5 , thus leading to stasis. Initial studies suggest increased plasma C5a levels in Towne-SS mice treated with isotype control IgG compared to mice treated with anti-C5 IgG in response to H/R. Conclusions These results demonstrate an increased percentage of SS-RBC expressing MAC on their surface and inhibition of H/R-induced stasis with anti-C5 IgG. However, circulating C5a levels were not different between untreated Townes-AA, -AS, or -SS mice suggesting that C5a is not chronically elevated in SCD. Rather, the generation of C5a may occur locally and in the acute setting. Current studies underway are examining the effects of anti-C5 IgG on MAC deposition and RBC half-lives; the mechanism(s) of complement activation in SCD mice (classical, alternative, tic-over, etc); the ability of recombinant murine C5a to induce stasis; and complement activation markers on RBC and in plasma from SCD patients and controls. Disclosures Chen: Imara: Research Funding. Belcher:Imara: Research Funding; CSL-Behring: Research Funding. Vercellotti:Imara: Research Funding; CSL-Behring: Research Funding." @default.
• W2762677209 created "2017-10-20" @default.
• W2762677209 creator A5009413569 @default.
• W2762677209 creator A5012545488 @default.
• W2762677209 creator A5029964640 @default.
• W2762677209 creator A5043649821 @default.
• W2762677209 creator A5054698119 @default.
• W2762677209 creator A5074865442 @default.
• W2762677209 creator A5076551817 @default.
• W2762677209 creator A5078016092 @default.
• W2762677209 creator A5082575546 @default.
• W2762677209 creator A5083169460 @default.
• W2762677209 creator A5087309905 @default.
• W2762677209 creator A5090785817 @default.
• W2762677209 date "2016-12-02" @default.
• W2762677209 modified "2023-09-30" @default.
• W2762677209 title "Complement Activation in a Murine Model of Sickle Cell Disease: Inhibition of Vaso-Occlusion By Blocking C5 Activation" @default.
• W2762677209 doi "https://doi.org/10.1182/blood.v128.22.158.158" @default.
• W2762677209 hasPublicationYear "2016" @default.
• W2762677209 type Work @default.
• W2762677209 sameAs 2762677209 @default.
• W2762677209 citedByCount "6" @default.
• W2762677209 countsByYear W27626772092018 @default.
• W2762677209 countsByYear W27626772092019 @default.
• W2762677209 crossrefType "journal-article" @default.
• W2762677209 hasAuthorship W2762677209A5009413569 @default.
• W2762677209 hasAuthorship W2762677209A5012545488 @default.
• W2762677209 hasAuthorship W2762677209A5029964640 @default.
• W2762677209 hasAuthorship W2762677209A5043649821 @default.
• W2762677209 hasAuthorship W2762677209A5054698119 @default.
• W2762677209 hasAuthorship W2762677209A5074865442 @default.
• W2762677209 hasAuthorship W2762677209A5076551817 @default.
• W2762677209 hasAuthorship W2762677209A5078016092 @default.
• W2762677209 hasAuthorship W2762677209A5082575546 @default.
• W2762677209 hasAuthorship W2762677209A5083169460 @default.
• W2762677209 hasAuthorship W2762677209A5087309905 @default.
• W2762677209 hasAuthorship W2762677209A5090785817 @default.
• W2762677209 hasConcept C111684460 @default.
• W2762677209 hasConcept C112516734 @default.
• W2762677209 hasConcept C153911025 @default.
• W2762677209 hasConcept C185592680 @default.
• W2762677209 hasConcept C189446657 @default.
• W2762677209 hasConcept C191590540 @default.
• W2762677209 hasConcept C203014093 @default.
• W2762677209 hasConcept C2777292125 @default.
• W2762677209 hasConcept C2778918659 @default.
• W2762677209 hasConcept C2779637612 @default.
• W2762677209 hasConcept C2910311954 @default.
• W2762677209 hasConcept C3018697912 @default.
• W2762677209 hasConcept C41625074 @default.
• W2762677209 hasConcept C55493867 @default.
• W2762677209 hasConcept C79196540 @default.
• W2762677209 hasConcept C86803240 @default.
• W2762677209 hasConcept C8891405 @default.
• W2762677209 hasConcept C89560881 @default.
• W2762677209 hasConcept C90582226 @default.
• W2762677209 hasConceptScore W2762677209C111684460 @default.
• W2762677209 hasConceptScore W2762677209C112516734 @default.
• W2762677209 hasConceptScore W2762677209C153911025 @default.
• W2762677209 hasConceptScore W2762677209C185592680 @default.
• W2762677209 hasConceptScore W2762677209C189446657 @default.
• W2762677209 hasConceptScore W2762677209C191590540 @default.
• W2762677209 hasConceptScore W2762677209C203014093 @default.
• W2762677209 hasConceptScore W2762677209C2777292125 @default.
• W2762677209 hasConceptScore W2762677209C2778918659 @default.
• W2762677209 hasConceptScore W2762677209C2779637612 @default.
• W2762677209 hasConceptScore W2762677209C2910311954 @default.
• W2762677209 hasConceptScore W2762677209C3018697912 @default.
• W2762677209 hasConceptScore W2762677209C41625074 @default.
• W2762677209 hasConceptScore W2762677209C55493867 @default.
• W2762677209 hasConceptScore W2762677209C79196540 @default.
• W2762677209 hasConceptScore W2762677209C86803240 @default.
• W2762677209 hasConceptScore W2762677209C8891405 @default.
• W2762677209 hasConceptScore W2762677209C89560881 @default.
• W2762677209 hasConceptScore W2762677209C90582226 @default.
• W2762677209 hasIssue "22" @default.
• W2762677209 hasLocation W27626772091 @default.
• W2762677209 hasOpenAccess W2762677209 @default.
• W2762677209 hasPrimaryLocation W27626772091 @default.
• W2762677209 hasRelatedWork W168986412 @default.
• W2762677209 hasRelatedWork W2011040278 @default.
• W2762677209 hasRelatedWork W2014279568 @default.
• W2762677209 hasRelatedWork W2035494890 @default.
• W2762677209 hasRelatedWork W2197048458 @default.
• W2762677209 hasRelatedWork W2762677209 @default.
• W2762677209 hasRelatedWork W3009812171 @default.
• W2762677209 hasRelatedWork W4238687432 @default.
• W2762677209 hasRelatedWork W4254662573 @default.
• W2762677209 hasRelatedWork W74287153 @default.
• W2762677209 hasVolume "128" @default.
• W2762677209 isParatext "false" @default.
• W2762677209 isRetracted "false" @default.
• W2762677209 magId "2762677209" @default.
• W2762677209 workType "article" @default.